Search - tctmd.com

Displaying 21 - 40 of 52

Sort: Relevancy | Date

News Conference News TCT 2018

Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR

TCT Daily Staff

September 28, 2018

News Conference News TCT 2017

TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG

Ashley Lyles

November 08, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day Two

Shelley Wood

October 31, 2017

News Conference News TCT 2016

Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients

Todd Neale

November 02, 2016

Presentation TCT 2016

Current Indications for TAVR: When Is TAVI Better Than Surgical AVR?

Presenter: Ziyad M. Hijazi, David W.M. Muller

November 01, 2016

Presentation TCT 2016

FFR in the setting of CABG and AS/AVR/TAVR

Presenter: Bernard De Bruyne, Allen Jeremias, Emanuele Barbato

November 01, 2016

Presentation TCT 2016

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Con Position

Presenter: Niall T. Mulvihill, Hellmuth Weich

October 31, 2016

Presentation TCT 2016

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Pro Position

Presenter: Niall T. Mulvihill, Antoniette Neylon

October 31, 2016

Presentation TCT 2016

Debate: TAVR for Low Risk Patients Is It time? NO, We Dont Yet Know if Its as Durable as Surgical AVR!

Presenter: Russell A. Brandwein, Isaac George

October 30, 2016

News Conference News TCT 2015

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

October 15, 2015

News Conference News TCT 2015

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

October 13, 2015

Presentation TCT 2014

Position Statement: TAVR Will Replace Surgical AVR in Low- and Intermediate-Risk Patients: Cath Labs Get Ready!

Presenter: Kishore J. Harjai, Susheel Kodali

September 14, 2014

News Conference News TCT 2014

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Yael L. Maxwell

September 13, 2014

News Conference News TCT 2013

TAVR, Surgical AVR Patients Show Similar Rates of Neurological Damage

November 03, 2013

Presentation TCT 2013

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - For: The Data are Clear (And Common Sense Rules): TAVR is a Lower Risk Option than...

Presenter: Daniel Blackman

October 30, 2013

Presentation TCT 2013

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - Against: The TAVR Data are Only on High-Risk Patients with Limited Follow-Up

Presenter: Charles Davidson

October 30, 2013

Presentation TCT 2013

Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR?

Presenter: Larry Wood

October 29, 2013

News Conference News TCT 2013

Opportunities Exist to Improve Outcomes in Transapical TAVR

October 29, 2013

Presentation TCT 2013

The High Frequency and Insidious Consequences of Bleeding Events After TAVR (and Surgical AVR)

Presenter: Philippe Généreux

October 28, 2013

Presentation TCT 2013

Incidence, Predictors, and Outcomes of Strokes After Surgical AVR and TAVR

Presenter: D. Craig Miller

October 28, 2013

Advertisement

Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR

TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG

Live From Denver: TCT 2017, Day Two

Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients

Current Indications for TAVR: When Is TAVI Better Than Surgical AVR?

FFR in the setting of CABG and AS/AVR/TAVR

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Con Position

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Pro Position

Debate: TAVR for Low Risk Patients Is It time? NO, We Dont Yet Know if Its as Durable as Surgical AVR!

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

Position Statement: TAVR Will Replace Surgical AVR in Low- and Intermediate-Risk Patients: Cath Labs Get Ready!

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

TAVR, Surgical AVR Patients Show Similar Rates of Neurological Damage

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - For: The Data are Clear (And Common Sense Rules): TAVR is a Lower Risk Option than...

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - Against: The TAVR Data are Only on High-Risk Patients with Limited Follow-Up

Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR?

Opportunities Exist to Improve Outcomes in Transapical TAVR

The High Frequency and Insidious Consequences of Bleeding Events After TAVR (and Surgical AVR)

Incidence, Predictors, and Outcomes of Strokes After Surgical AVR and TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content